IRVINE, CA -- (MARKET WIRE) -- September 12, 2006 -- BIOLASE Technology, Inc. (NASDAQ: BLTI), a medical technology company that develops, manufactures and markets lasers and related products focused on technologies for improved applications and procedures in dentistry and medicine, announced today that it will participate in a conference call hosted by medical technology analyst, Alex Arrow, M.D. of Lazard Capital Markets, providing additional strategic and financial details on the recently announced distribution alliance with Henry Schein, Inc. (NASDAQ: HSIC), the largest provider of healthcare products and services to office-based practitioners in the combined North American and European markets.
